Analysis of the publicly available online KaplanMeier plotter dataset [23] revealed that patients with ovarian, lung, or gastric cancer and high expression of CTBP1-DT lncRNA had significantly shorter overall and progression-free survival compared to those of patients with low expression of CTBP1-DT lncRNA (Fig. 1A, B). The gene discussed is CTBP1; the disease is gastric cancer.